BPA - Consumable Supplies for Terumo Trima Accel Blood Collection systems
DEPT OF DEFENSE.DEFENSE HEALTH AGENCY (DHA).ARMY MED RES ACQ ACTIVITY · Response deadline: Fri, 06 Nov 2026
What the government is buying
The Defense Health Agency (DHA), through its Army Medical Research Acquisition Activity, is soliciting offers for consumable supplies used with Terumo Trima Accel automated blood collection systems. These are specialized medical devices used for apheresis procedures—drawing blood components such as platelets, plasma, or red blood cells while returning other components to the donor.
The requirement is structured as a Blanket Purchase Agreement (BPA), meaning this is a simplified acquisition vehicle for repetitive purchases rather than a single delivery order. BPAs for medical consumables typically streamline ordering for items the government buys frequently but in variable quantities. The Terumo Trima Accel system requires proprietary or system-specific disposables; common consumables for this platform include collection sets, separation kits, anticoagulant solutions, and tubing sets. See the solicitation for the specific items, estimated quantities, and any approved equivalent products.
Key facts
| Attribute | Value |
|---|---|
| Agency | Defense Health Agency (DHA), Army Medical Research Acquisition Activity |
| Notice type | Solicitation |
| Solicitation number | HT942627QE003 |
| NAICS | 325413 – In-vitro Diagnostic Substance Manufacturing |
| Set-aside | Service-Disabled Veteran-Owned Small Business (SDVOSB) Set-Aside (FAR 19.14) |
| Response deadline | November 6, 2026, 12:00 PM ET |
| Place of performance | Texas (unspecified / multiple) |
Who can bid
This opportunity is strictly set aside for Service-Disabled Veteran-Owned Small Businesses (SDVOSBs) that meet the size standard under NAICS 325413. Your firm must be at least 51% unconditionally owned and controlled by one or more service-disabled veterans, with day-to-day operations and long-term strategic management directed by such veteran(s). You must be certified in SAM.gov as an SDVOSB and maintain that status through award.
Manufacturers of in-vitro diagnostic substances and medical device suppliers with distribution relationships may qualify if they meet the SDVOSB eligibility criteria. If you are an authorized distributor for Terumo products rather than a manufacturer, you must confirm your supply chain relationships and whether the prime contract holder can satisfy the set-aside requirements. See the solicitation for any mandatory manufacturer authorization letters or sole-source justifications.
How to put together a competitive bid
Verify product compatibility. The Trima Accel platform has proprietary consumable requirements. Confirm whether the solicitation specifies exact Terumo part numbers or allows equivalent products approved by the FDA and Terumo for use on this system. Obtain technical specifications and cross-reference your catalog carefully.
Understand BPA dynamics. BPAs establish ceiling amounts or ordering limits but do not guarantee sales volume. Propose competitive unit pricing that accounts for the potential for repeat, smaller orders rather than bulk-volume assumptions. Review any economic price adjustment clauses for multi-year purchasing.
Demonstrate medical supply chain reliability. DHA's blood collection operations depend on consistent supply availability. Highlight your inventory management, stock rotation for dated medical products, cold-chain or controlled-environment shipping capabilities if required, and past performance delivering to military medical facilities.
Address SDVOSB compliance explicitly. Include your SAM.gov certification date, veteran ownership documentation, and any VA-verified status. Past experience with federal medical supply contracts strengthens your proposal; if limited, emphasize commercial healthcare experience and relevant quality certifications (ISO 13485, cGMP).
Next steps
Download the full solicitation package from SAM.gov using solicitation number HT942627QE003. Review all line items, technical specifications, evaluation factors, and any warranted-equivalents language. Note the firm response deadline of November 6, 2026, at 12:00 PM Eastern Time—late submissions are inadmissible under federal acquisition regulations. Allow adequate time for SAM.gov registration updates, teaming agreement finalization if needed, and proposal assembly.
View the official notice on SAM.gov →